MESA LABORATORIES INC /CO/(MLAB)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,557 of 2,960 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
Unusual Activity in MLAB
Events flagged as statistical outliers against MLAB's own multi-year baseline — not fixed dollar thresholds.
- Insider cluster2026-08-13
2 insiders bought $902,411 of MLAB in 30 days — 3.1σ above this company's 2-year norm
View source filing → - Score shock2026-08-11
MLAB quality score dropped 9 points (58→49) on a new filing
View source filing →
MLAB Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for MESA LABORATORIES INC /CO/ (MLAB), a Technology sector company. 13F Pro's AI-powered ranking engine scores MLAB at 51.1/100 on a 32-signal composite quality model, placing it at rank #1,557 of 2,960 stocks — the bottom half of the AI-ranked universe. MLAB scores in the top quartile across earnings quality (94.2). Areas of concern include revenue scale (26.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 20.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), MESA LABORATORIES INC /CO/ reports quarterly revenue of $60.1M, net income of $2.8M, an operating margin of 11.7%. Top institutional holders of MLAB by reported 13-F value include Long Path Partners, BlackRock, Boston Partners, based on the most recent SEC filings. MLAB trades on the Nasdaq exchange and files with the SEC under CIK 724004. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MLAB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MESA LABORATORIES INC /CO/ directly from SEC EDGAR. MESA LABORATORIES INC /CO/'s 13F Pro composite quality score has ranged between 42 and 56 since 2021, currently 51.1 — a declining long-term trajectory across 68 quarterly and live scoring snapshots.
Revenue
Q2 2026
$60.1M
Net Income
Q2 2026
$2.8M
Free Cash Flow
Q2 2026
$14.2M
Operating Margin
Q2 2026
11.7%
ROIC
Q2 2026
11.0%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+3.4% YoYNet Income
+440.0% YoYOperating Income
+13.3% YoYEPS (Diluted)
+436.1% YoYTotal Assets
-1.3% YoYTotal Debt
-5.3% YoYOp. Cash Flow
-8.5% YoYFree Cash Flow
-7.0% YoY| Metric | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $249.1M +3.4% | $241.0M +11.5% | $216.2M -1.3% | $219.1M +18.8% | $184.3M +37.6% | $133.9M |
| Net Income | $6.7M +440.0% | $-2.0M +99.2% | $-254.2M -27438.3% | $930.0K -50.3% | $1.9M -42.9% | $3.3M |
| Operating Income | $18.5M +13.3% | $16.3M +106.0% | $-272.1M -8295.0% | $3.3M -29.4% | $4.7M -62.0% | $12.4M |
| EPS (Diluted) | $1.21 +436.1% | $-0.36 +99.2% | $-47.20 -27864.7% | $0.17 -51.4% | $0.35 -45.3% | $0.64 |
| Total Assets | $427.7M -1.3% | $433.3M -3.0% | $446.8M -32.5% | $661.8M -6.4% | $707.4M +17.6% | $601.5M |
| Total Debt | $67.5M -5.3% | $71.3M | — | — | — | — |
| Operating Cash Flow | $42.8M -8.5% | $46.8M +6.1% | $44.1M +57.7% | $28.0M -28.7% | $39.2M +5.8% | $37.1M |
| Free Cash Flow | $39.6M -7.0% | $42.6M +2.4% | $41.6M +77.3% | $23.4M -32.6% | $34.8M -0.8% | $35.1M |
Get alerted when MLAB's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for MESA LABORATORIES INC /CO/ including:
Top Institutional Holders of MLAB
Long Path Partners LP
$47.5M477,126 shBlackRock, Inc.
$43.9M440,552 shBoston Partners
$26.4M265,149 shVANGUARD CAPITAL MANAGEMENT LLC
$23.6M237,457 shAQR CAPITAL MANAGEMENT LLC
$20.3M203,739 shRanger Investment Management, L.P.
$17.3M173,988 shMORGAN STANLEY
$15.6M156,979 shDIAMOND HILL CAPITAL MANAGEMENT INC
$15.5M155,771 shRAYMOND JAMES FINANCIAL INC
$14.9M149,937 shDIMENSIONAL FUND ADVISORS LP
$14.8M148,395 sh
| Fund | Value | Shares |
|---|---|---|
| Long Path Partners LP | $47.5M | 477,126 |
| BlackRock, Inc. | $43.9M | 440,552 |
| Boston Partners | $26.4M | 265,149 |
| VANGUARD CAPITAL MANAGEMENT LLC | $23.6M | 237,457 |
| AQR CAPITAL MANAGEMENT LLC | $20.3M | 203,739 |
| Ranger Investment Management, L.P. | $17.3M | 173,988 |
| MORGAN STANLEY | $15.6M | 156,979 |
| DIAMOND HILL CAPITAL MANAGEMENT INC | $15.5M | 155,771 |
| RAYMOND JAMES FINANCIAL INC | $14.9M | 149,937 |
| DIMENSIONAL FUND ADVISORS LP | $14.8M | 148,395 |
Companies Similar to MLAB
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
nCino, Inc.
i3 Verticals, Inc.
HEALTHSTREAM INC
OOMA INC
Simulations Plus, Inc.
ALKAMI TECHNOLOGY, INC.
WORKIVA INC
Commerce.com, Inc.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Technology Companies
View all Technology →Put MLAB on your watchlist
Track score changes the day MESA LABORATORIES INC /CO/ files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is MLAB a good stock to buy?
13F Pro's AI-powered analysis of MESA LABORATORIES INC /CO/ (MLAB) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MLAB are available on the MLAB stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. MLAB is classified as a small company.
Which hedge funds own MLAB?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MLAB. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of MESA LABORATORIES INC /CO/'s investment landscape.